NO20005839L - Preparater for behandling av HIV og andre virale infeksjoner - Google Patents

Preparater for behandling av HIV og andre virale infeksjoner

Info

Publication number: NO20005839L
Authority: NO; Norway
Prior art keywords: hiv; virus; hydrogen; carbon atoms; prevent
Prior art date: 1998-05-19

Application number

NO20005839A

Other languages

English (en)

Norwegian (no)

Other versions

NO20005839D0 (no

Inventor

James Berger Camden

Original Assignee

Procter & Gamble

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-05-19

Filing date

2000-11-17

Publication date

2001-01-16

2000-11-17 Application filed by Procter & Gamble filed Critical Procter & Gamble

2000-11-17 Publication of NO20005839D0 publication Critical patent/NO20005839D0/no

2001-01-16 Publication of NO20005839L publication Critical patent/NO20005839L/no

Links

208000036142 Viral infection Diseases 0.000 title abstract 2
238000002360 preparation method Methods 0.000 title abstract 2
230000009385 viral infection Effects 0.000 title abstract 2
241000725303 Human immunodeficiency virus Species 0.000 abstract 4
241000700605 Viruses Species 0.000 abstract 4
125000004432 carbon atom Chemical group C* 0.000 abstract 3
229910052739 hydrogen Inorganic materials 0.000 abstract 3
239000001257 hydrogen Substances 0.000 abstract 3
125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 3
125000000217 alkyl group Chemical group 0.000 abstract 2
HYZJCKYKOHLVJF-UHFFFAOYSA-N 1H-benzimidazole Chemical compound C1=CC=C2NC=NC2=C1 HYZJCKYKOHLVJF-UHFFFAOYSA-N 0.000 abstract 1
KDDQRKBRJSGMQE-UHFFFAOYSA-N 4-thiazolyl Chemical group [C]1=CSC=N1 KDDQRKBRJSGMQE-UHFFFAOYSA-N 0.000 abstract 1
ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical group [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 abstract 1
241000709661 Enterovirus Species 0.000 abstract 1
208000031886 HIV Infections Diseases 0.000 abstract 1
208000037357 HIV infectious disease Diseases 0.000 abstract 1
XQFRJNBWHJMXHO-RRKCRQDMSA-N IDUR Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(I)=C1 XQFRJNBWHJMXHO-RRKCRQDMSA-N 0.000 abstract 1
125000003545 alkoxy group Chemical group 0.000 abstract 1
239000003443 antiviral agent Substances 0.000 abstract 1
150000001556 benzimidazoles Chemical class 0.000 abstract 1
230000015572 biosynthetic process Effects 0.000 abstract 1
229910052801 chlorine Inorganic materials 0.000 abstract 1
239000000460 chlorine Chemical group 0.000 abstract 1
150000001875 compounds Chemical class 0.000 abstract 1
125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 abstract 1
229910052736 halogen Inorganic materials 0.000 abstract 1
150000002367 halogens Chemical group 0.000 abstract 1
208000006454 hepatitis Diseases 0.000 abstract 1
231100000283 hepatitis Toxicity 0.000 abstract 1
208000033519 human immunodeficiency virus infectious disease Diseases 0.000 abstract 1
208000015181 infectious disease Diseases 0.000 abstract 1
206010022000 influenza Diseases 0.000 abstract 1
230000002401 inhibitory effect Effects 0.000 abstract 1
239000000203 mixture Substances 0.000 abstract 1
-1 nitro, oxychloro, methyl Chemical group 0.000 abstract 1
239000000825 pharmaceutical preparation Substances 0.000 abstract 1
230000010076 replication Effects 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1
241001529453 unidentified herpesvirus Species 0.000 abstract 1
241000712461 unidentified influenza virus Species 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Chemical & Material Sciences (AREA)
Epidemiology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Immunology (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Virology (AREA)
General Chemical & Material Sciences (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Molecular Biology (AREA)
Tropical Medicine & Parasitology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
AIDS & HIV (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)

NO20005839A 1998-05-19 2000-11-17 Preparater for behandling av HIV og andre virale infeksjoner NO20005839L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US8138498A	1998-05-19	1998-05-19
PCT/US1999/011059 WO1999059585A1 (en)	1998-05-19	1999-05-19	Compositions for the treatment of hiv and other viral infections

Publications (2)

Publication Number	Publication Date
NO20005839D0 NO20005839D0 (no)	2000-11-17
NO20005839L true NO20005839L (no)	2001-01-16

Family

ID=22163807

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20005839A NO20005839L (no)	1998-05-19	2000-11-17	Preparater for behandling av HIV og andre virale infeksjoner

Country Status (19)

Country	Link
US (1)	US6245789B1 (id)
EP (1)	EP1079831A1 (id)
JP (1)	JP2002515432A (id)
KR (1)	KR20010043709A (id)
CN (1)	CN1301158A (id)
AR (1)	AR019305A1 (id)
AU (1)	AU4004299A (id)
BR (1)	BR9911043A (id)
CA (1)	CA2329877A1 (id)
CO (1)	CO5050303A1 (id)
HU (1)	HUP0103319A2 (id)
ID (1)	ID27457A (id)
IL (1)	IL139002A0 (id)
NO (1)	NO20005839L (id)
PE (1)	PE20000550A1 (id)
PL (1)	PL344223A1 (id)
SK (1)	SK17442000A3 (id)
TR (1)	TR200003383T2 (id)
WO (1)	WO1999059585A1 (id)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6262093B1 (en)	1995-04-12	2001-07-17	The Proctor & Gamble Company	Methods of treating cancer with benzimidazoles
US6479526B1 (en)	1995-04-12	2002-11-12	The Procter & Gamble Company	Pharmaceutical composition for inhibiting the growth of viruses and cancers
US6177460B1 (en)	1995-04-12	2001-01-23	The Procter & Gamble Company	Method of treatment for cancer or viral infections
US6265427B1 (en)	1995-06-07	2001-07-24	The Proctor & Gamble Company	Pharmaceutical composition for the method of treating leukemia
US5770616A (en)	1995-06-07	1998-06-23	The Procter & Gamble Company	Pharmaceutical composition for inhibiting the growth of cancers
US6686391B2 (en)	1995-08-04	2004-02-03	University Of Arizona Foundation	N-chlorophenylcarbamate and N-chlorophenylthiocarbamate compositions
US5900429A (en)	1997-01-28	1999-05-04	The Procter & Gamble Company	Method for inhibiting the growth of cancers
US6506783B1 (en)	1997-05-16	2003-01-14	The Procter & Gamble Company	Cancer treatments and pharmaceutical compositions therefor
US6245789B1 (en)	1998-05-19	2001-06-12	The Procter & Gamble Company	HIV and viral treatment
US6423734B1 (en)	1999-08-13	2002-07-23	The Procter & Gamble Company	Method of preventing cancer
US6242461B1 (en) *	2000-01-25	2001-06-05	Pfizer Inc.	Use of aryl substituted azabenzimidazoles in the treatment of HIV and AIDS related diseases
PE20020506A1 (es)	2000-08-22	2002-07-09	Glaxo Group Ltd	Derivados de pirazol fusionados como inhibidores de la proteina cinasa
US6407105B1 (en) *	2000-09-26	2002-06-18	The Procter & Gamble Company	Compounds and methods for use thereof in the treatment of cancer or viral infections
US6462062B1 (en)	2000-09-26	2002-10-08	The Procter & Gamble Company	Compounds and methods for use thereof in the treatment of cancer or viral infections
US6608096B1 (en)	2000-09-26	2003-08-19	University Of Arizona Foundation	Compounds and methods for use thereof in the treatment of cancer or viral infections
US6380232B1 (en)	2000-09-26	2002-04-30	The Procter & Gamble Company	Benzimidazole urea derivatives, and pharmaceutical compositions and unit dosages thereof
WO2002041891A2 (en) *	2000-11-01	2002-05-30	The Procter & Gamble Company	Hiv treatment with benzimidazoles
ATE301653T1 (de)	2000-12-15	2005-08-15	Glaxo Group Ltd	Pyrazolopyridine
WO2002048148A2 (en)	2000-12-15	2002-06-20	Glaxo Group Limited	Pyrazolopyridine derivatives
DE60201074T2 (de)	2001-03-08	2005-09-15	Smithkline Beecham Corp.	Pyrazolopyridinderivate
EP1372643A1 (en)	2001-03-30	2004-01-02	Smithkline Beecham Corporation	Pyrazolopyridines, process for their preparation and use as therapeutic compounds
US7141569B2 (en)	2001-04-10	2006-11-28	Smithkline Beecham Corporation	Antiviral pyrazolopyridine compounds
ES2242028T3 (es)	2001-04-27	2005-11-01	Smithkline Beecham Corporation	Derivados de pirazolo(1,5-a)piridina.
HUP0400266A2 (hu) *	2001-06-21	2004-08-30	Smithkline Beecham Corp.	Imidazo[1,2-a]piridin-származékok, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk herpeszvírus-fertőzések megelőzésére vagy kezelésére
WO2003031446A1 (en)	2001-10-05	2003-04-17	Smithkline Beecham Corporation	Imidazo-pyridine derivatives for use in the treatment of herpes viral infection
AU2002357740A1 (en) *	2001-12-11	2003-06-23	Smithkline Beecham Corporation	Pyrazolo-pyridine derivatives as antiherpes agents
WO2003082273A1 (en) *	2002-03-26	2003-10-09	Arizona Board Of Regents On Behalf Of The University Of Arizona	Solubilization of weak bases
JP2006504728A (ja)	2002-10-03	2006-02-09	スミスクラインビーチャムコーポレーション	ピラソロピリジン誘導体系治療用化合物
AU2003900064A0 (en) *	2003-01-09	2003-01-23	Penam Investments Pty. Ltd.	A method of treatment or prophylaxis of viral infection.
JP2005060362A (ja) *	2003-07-28	2005-03-10	Shionogi & Co Ltd	セスキテルペン誘導体を含有する抗ＨＩＶ剤、抗ＢＶＤＶ剤、抗ＨＣＶ剤又は抗ＣｏＶ剤
EP2251010A1 (en)	2009-05-08	2010-11-17	Sygnis Bioscience GmbH & Co. KG	Use of thiabendazole and derivatives thereof for the therapy of neurological conditions
US9655962B2 (en) *	2013-03-15	2017-05-23	Camas Incorporated	Methods and compositions for reducing microorganisms in the oropharynx, nasopharynx and oral cavities
FR3057865A1 (fr) *	2016-10-21	2018-04-27	Laboratoire Michel Iderne	Composition chimique
TW201936193A (zh) *	2017-12-05	2019-09-16	愛爾蘭商健生科學愛爾蘭無限公司	使用組合產品治療ｒｓｖ
KR102342313B1 (ko)	2021-08-27	2021-12-24	(주)바이오메트릭스 테크놀로지	벤지미다졸-탄수화물 결합체 화합물을 포함하는 미셀, 이의 제조방법, 이의 항암제 또는 항바이러스제로서의 용도

Family Cites Families (42)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3010968A (en)	1959-11-25	1961-11-28	Du Pont	Process for manufacture of certain alkyl esters of benzimidazole carbamic acids
NL134354C (id)	1963-05-23
US3499761A (en)	1964-07-20	1970-03-10	Gaf Corp	Silver halide emulsions containing alkyl esters of benzimidazole carbamic acid antifogging agents
US3541213A (en)	1966-05-06	1970-11-17	Du Pont	Fungicidal and mite ovicidal substituted 2-aminobenzimidazoles
US3881014A (en)	1968-11-05	1975-04-29	Bayer Ag	N-tritylimidazoles for treating fungal infections
BE759337A (fr)	1969-11-24	1971-05-24	Lilly Co Eli	Benzimidazol (2,1-b)-quinazolin (6h) ones qui sont des immuno-depresseurs, et nouvelles benzimidazo (2,1-b) quinazolin-12-(6h) ones
US3956262A (en)	1970-12-09	1976-05-11	Beecham Group Limited	Triazenoimidazoles
US3738995A (en)	1971-05-14	1973-06-12	Du Pont	Solvent process for the preparation of 1 - carbamoyl-substituted 2 - benzimidazolecarbamates
FR2155888A1 (en)	1971-10-13	1973-05-25	Agot Aime	Solid anthelmintic composn - for more economical treatment of ruminants
US4046906A (en)	1973-04-21	1977-09-06	Hoechst Aktiengesellschaft	Salts of alkyl 2-benzimidazole-carbamate
HU193951B (en)	1985-03-11	1987-12-28	Richter Gedeon Vegyeszet	Process for producing new sulfur-containing 5-substituted benzimidazol derivatives and pharmaceutical compositions containing them
US4731366A (en)	1986-08-05	1988-03-15	Harbor Branch Oceanographic Institution, Inc.	Discorhabdin compositions and their methods of use
GB2210875B (en)	1987-10-09	1991-05-29	Farmos Oy	Aromatase inhibiting 4(5)-imidazoles
US5329012A (en)	1987-10-29	1994-07-12	The Research Foundation Of State University Of New York	Bis(acyloxmethyl)imidazole compounds
US5114951A (en)	1989-04-11	1992-05-19	Burroughs Wellcome Company	Agents for combating multiple drug resistance
US5149527A (en)	1990-09-18	1992-09-22	Oncotech, Inc.	Immunopotentiating protocol for chemotherapy-responsive tumors
US5310748A (en)	1992-05-11	1994-05-10	The Du Pont Merck Pharmaceutical Company	Imidazoles for the treatment of atherosclerosis
US5364875A (en)	1992-05-11	1994-11-15	The Du Pont Merck Pharmaceutical Company	Imidazoles linked to bicyclic heterocyclic groups for the treatment of atherosclerosis
US5290801A (en)	1992-05-29	1994-03-01	The Du Pont Merck Pharmaceutical Company	Benzimidazoles for the treatment of atherosclerosis
KR950702994A (ko)	1992-08-12	1995-08-23	로렌스 티. 웰츠	탁솔과 복합된, 단백질 키나제 억제제 및 관련 화합물(protein kinase inhibitors and related compounds combined with taxol)
RU2139052C1 (ru)	1993-03-31	1999-10-10	Мерк Энд Ко., Инк.	Комбинация ингибитора вич-протеазы с другими антивирусными соединениями, фармацевтическая композиция на их основе и способ получения фармацевтической композиции
US5434163A (en)	1993-05-14	1995-07-18	The Medical College Of Pennsylvania	Treatment of Cryptococcus neoformans infection
JP3213471B2 (ja)	1994-04-13	2001-10-02	ポーラ化成工業株式会社	薬効成分含有リポソーム製剤の製造方法
US5656615A (en)	1995-04-12	1997-08-12	The Procter & Gamble Company	Pharmaceutical composition for inhibiting the growth of cancers and viruses in mammals
EP0820281B1 (en)	1995-04-12	2007-07-25	UAF Technologies and Research, LLC	A pharmaceutical composition containing n-chlorophenylcarbamates and n-chlorophenylthiocarbamates for inhibiting the growth of viruses
US5629341A (en)	1995-04-12	1997-05-13	The Procter & Gamble Company	Pharmaceutical composition for inhibiting the growth of viruses and cancers
ZA962880B (en)	1995-04-12	1997-03-17	Procter & Gamble	A pharmaceutical composition for inhibiting the growth of viruses and cancers
US5665713A (en)	1995-04-12	1997-09-09	Procter & Gamble Company	Pharmaceutical composition for inhibiting the growth of viruses and cancers
NZ305784A (en)	1995-04-12	2001-03-30	Procter & Gamble	Benzimidazole containing medicaments for treating cancers, tumors and viral infections
ZA962879B (en) *	1995-04-12	1997-03-17	Procter & Gamble	A pharmaceutical composition for inhibiting the growth of viruses and cancers
US5770616A (en)	1995-06-07	1998-06-23	The Procter & Gamble Company	Pharmaceutical composition for inhibiting the growth of cancers
MX9707809A (es)	1995-06-07	1998-01-31	Procter & Gamble	Una composicion farmaceutica que contiene bencimidazol para inhibir el crecimiento de canceres.
US5665751A (en)	1995-06-07	1997-09-09	The Procter & Gamble Company	Pharmaceutical composition for inhibiting the growth of cancers
SK168697A3 (en)	1995-06-07	1998-12-02	Procter & Gamble	A medicament for the treatment of leukemia
US6200992B1 (en)	1995-06-07	2001-03-13	The Procter & Gamble Company	Pharmaceutical composition for inhibiting the growth of cancers
TR199800244T2 (xx)	1995-08-03	1998-09-21	The Procter & Gamble Company	Griseofulvinin, kanserlerin ilerlemesini �nlemede kullan�m�.
PL324904A1 (en)	1995-08-04	1998-06-22	Procter & Gamble	Application of fluconazole in carcinoma development inhibition
US5908855A (en)	1996-07-16	1999-06-01	The Procter & Gamble Company	Compositions for treating viral infections
US5900429A (en)	1997-01-28	1999-05-04	The Procter & Gamble Company	Method for inhibiting the growth of cancers
PE11499A1 (es)	1997-05-16	1999-03-01	Procter & Gamble	Tratamiento del hiv y cancer
US6506783B1 (en)	1997-05-16	2003-01-14	The Procter & Gamble Company	Cancer treatments and pharmaceutical compositions therefor
US6245789B1 (en)	1998-05-19	2001-06-12	The Procter & Gamble Company	HIV and viral treatment

1999
- 1999-05-17 US US09/312,949 patent/US6245789B1/en not_active Expired - Fee Related
- 1999-05-19 WO PCT/US1999/011059 patent/WO1999059585A1/en not_active Ceased
- 1999-05-19 AR ARP990102384A patent/AR019305A1/es unknown
- 1999-05-19 SK SK1744-2000A patent/SK17442000A3/sk unknown
- 1999-05-19 CA CA002329877A patent/CA2329877A1/en not_active Abandoned
- 1999-05-19 BR BR9911043-1A patent/BR9911043A/pt not_active IP Right Cessation
- 1999-05-19 EP EP99923219A patent/EP1079831A1/en not_active Withdrawn
- 1999-05-19 CN CN99806363A patent/CN1301158A/zh active Pending
- 1999-05-19 AU AU40042/99A patent/AU4004299A/en not_active Abandoned
- 1999-05-19 JP JP2000549250A patent/JP2002515432A/ja not_active Withdrawn
- 1999-05-19 CO CO99030834A patent/CO5050303A1/es unknown
- 1999-05-19 IL IL13900299A patent/IL139002A0/xx unknown
- 1999-05-19 PL PL99344223A patent/PL344223A1/xx unknown
- 1999-05-19 KR KR1020007012938A patent/KR20010043709A/ko not_active Ceased
- 1999-05-19 TR TR2000/03383T patent/TR200003383T2/xx unknown
- 1999-05-19 PE PE1999000422A patent/PE20000550A1/es not_active Application Discontinuation
- 1999-05-19 ID IDW20002656A patent/ID27457A/id unknown
- 1999-05-19 HU HU0103319A patent/HUP0103319A2/hu unknown
2000
- 2000-11-17 NO NO20005839A patent/NO20005839L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
PE20000550A1 (es)	2000-06-29
ID27457A (id)	2001-04-12
NO20005839D0 (no)	2000-11-17
IL139002A0 (en)	2001-11-25
TR200003383T2 (tr)	2001-03-21
SK17442000A3 (sk)	2001-08-06
US6245789B1 (en)	2001-06-12
PL344223A1 (en)	2001-10-08
WO1999059585A1 (en)	1999-11-25
AR019305A1 (es)	2002-02-13
EP1079831A1 (en)	2001-03-07
CA2329877A1 (en)	1999-11-25
KR20010043709A (ko)	2001-05-25
HUP0103319A2 (hu)	2002-05-29
CO5050303A1 (es)	2001-06-27
JP2002515432A (ja)	2002-05-28
CN1301158A (zh)	2001-06-27
BR9911043A (pt)	2001-02-13
AU4004299A (en)	1999-12-06

Legal Events

Date	Code	Title	Description
2003-01-27	FC2A	Withdrawal, rejection or dismissal of laid open patent application

Publication	Publication Date	Title
BR9911043A (pt)	2001-02-13	Composição para o tratamento do hiv e outras infecções viróticas
MX2024015459A (es)	2025-02-10	Compuestos de carbamoilpiridona triciclica puenteada y su uso farmaceutico
MXPA04012779A (es)	2005-08-19	Profarmacos de 2'- y 3'-nucleosido para tratar infecciones por flaviviridae.
TW200500375A (en)	2005-01-01	Modified 2' and 3'-nucleoside prodrugs for treating flaviviridae
NO20052130L (no)	2005-04-29	Sterk inhibitor for HCV-serin-protease
MA57933B1 (fr)	2024-09-30	Composés hautement actifs contre la covid-19
WO1998056761A3 (en)	1999-04-15	Benzimidazole derivatives
TW427887B (en)	2001-04-01	Pharmaceutical composition comprising a benzimidazole derivative for treating viral infections
RU2011127080A (ru)	2013-02-20	Производное циклоспорина для применения в лечении заражения вирусом гепатита с и вич
NZ609146A (en)	2014-08-29	Modified 4’-nucleosides as antiviral agents
GEP20053601B (en)	2005-08-10	Nucleoside Derivatives as Inhibitors of RNA-Dependent RNA Viral Polymerase
NO20072689L (no)	2007-07-17	Tetrasykliske indolderivater som antivirale midler
NZ610715A (en)	2014-07-25	Antiviral compounds and methods
SG171596A1 (en)	2011-06-29	Nucleoside aryl phosphoramidates and their use as anti-viral agents for the treatment of hepatitis c virus
WO2007076034A3 (en)	2007-10-04	Anti-viral compounds
WO2007076035A3 (en)	2007-10-04	Anti-viral compounds
NO20041631L (no)	2004-05-26	Piperazinderivater med CCR1 reseptor antagonist
MXPA02001571A (es)	2003-10-14	Metodo de tratamiento para el cancer.
MXPA06000418A (es)	2006-04-05	Derivados de ariltiourea sustituida utiles como inhibidores de duplicacion viral.
WO2004037784A3 (en)	2004-08-19	Pyrrolidones with anti-hiv activity
WO2021055425A3 (en)	2021-04-29	Functionalized heterocycles as antiviral agents
CA2365495A1 (en)	2000-10-05	Viral treatment
WO2007106450A3 (en)	2009-04-02	Diketo acids with nucleobase scaffolds: anti-hiv replication inhibitors targeted at hiv integrase in combination therapy
WO2006083553A3 (en)	2007-04-19	Diketo acids with nucleobase scaffolds: anti-hiv replication inhibitors targeted at hiv integrase
US4005224A (en)	1977-01-25	Method of combating influenza type A and B and parainfluenza type 3 viruses with aminospiranes and aminoalkylspiranes